Chemoinformaics analysis of TRIDECYL 2,2,2-TRIFLUOROACETATE
| Molecular Weight | 296.373 | nRot | 12 |
| Heavy Atom Molecular Weight | 269.157 | nRig | 0 |
| Exact Molecular Weight | 296.196 | nRing | 0 |
| Solubility: LogS | -6.409 | nHRing | 0 |
| Solubility: LogP | 6.462 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.3284 |
| nHD | 0 | BPOL | 33.0296 |
| QED | 0.464 |
| Synth | 2.773 |
| Natural Product Likeliness | 0.976 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.026 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.385 |
| MDCK | 0.0000104 |
| BBB | 0.494 |
| PPB | 0.976587 |
| VDSS | 2.878 |
| FU | 0.0211686 |
| CYP1A2-inh | 0.895 |
| CYP1A2-sub | 0.337 |
| CYP2c19-inh | 0.507 |
| CYP2c19-sub | 0.714 |
| CYP2c9-inh | 0.532 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.156 |
| CYP2d6-sub | 0.062 |
| CYP3a4-inh | 0.127 |
| CYP3a4-sub | 0.134 |
| CL | 7.175 |
| T12 | 0.107 |
| hERG | 0.041 |
| Ames | 0.005 |
| ROA | 0.029 |
| SkinSen | 0.878 |
| Carcinogencity | 0.046 |
| EI | 0.971 |
| Respiratory | 0.365 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.690136 |